Indeed effectiveness could be in excess of 43% if used on patients where inflamation has been tamed by other treatments before Rem-L got to be used.
MSC's seek out inflamed site to do their thing!
The evidence for Rem-L being used as first or second treatment is mounting.
Indeed effectiveness could be in excess of 43% if used on...
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.055(5.16%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | $1.00 | $1.647M | 1.614M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 49809 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 41224 | 19 |
View Market Depth
| Last trade - 11.44am 04/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |